These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
350 related items for PubMed ID: 9684808
21. Comparative studies on the anticoagulant and protease generation inhibitory actions of newly developed site-directed thrombin inhibitory drugs. Efegatran, argatroban, hirulog, and hirudin. Callas DD, Hoppensteadt D, Fareed J. Semin Thromb Hemost; 1995; 21(2):177-83. PubMed ID: 7660140 [Abstract] [Full Text] [Related]
22. Inhibition of platelet deposition by combined hirulog and aspirin in a rat carotid endarterectomy model. Hamelink JK, Tang DB, Barr CF, Jackson MR, Reid TJ, Gomez ER, Alving BM. J Vasc Surg; 1995 Mar; 21(3):492-8. PubMed ID: 7877232 [Abstract] [Full Text] [Related]
34. Adjunctive use of direct thrombin inhibitors in patients receiving fibrinolytic therapy for acute myocardial infarction. French JK, Edmond JJ, Gao W, White HD, Eikelboom JW. Am J Cardiovasc Drugs; 2004 Oct; 4(2):107-15. PubMed ID: 15049722 [Abstract] [Full Text] [Related]
35. Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial. Rao AK, Sun L, Chesebro JH, Fuster V, Harrington RA, Schwartz D, Gallo P, Matos D, Topol EJ. Circulation; 1996 Nov 15; 94(10):2389-95. PubMed ID: 8921778 [Abstract] [Full Text] [Related]
37. Initial experience with a direct antithrombin, Hirulog, in unstable angina. Anticoagulant, antithrombotic, and clinical effects. Lidón RM, Théroux P, Juneau M, Adelman B, Maraganore J. Circulation; 1993 Oct 15; 88(4 Pt 1):1495-501. PubMed ID: 8403297 [Abstract] [Full Text] [Related]